Trademark applications and grants for Eureka Therapeutics, Inc.. Eureka Therapeutics, Inc. has 6 trademark applications. The latest application filed is for "INVISIMASK"
State Incorporated | DELAWARE |
Entity Type | CORPORATION |
Address | 5858 Horton St, Suite 170 Emeryville, CALIFORNIA UNITED STATES 94608 |
Patent Application | Date |
---|---|
FOXP3 TARGETING AGENT COMPOSITIONS AND METHODS OF USE FOR ADOPTIVE CELL THERAPY 20220267420 - 16/970332 SCHEINBERG; David A. ;   et al. | 2022-08-25 |
CHIMERIC ANTIGEN RECEPTOR T CELLS AND USES THEREOF 20220265715 - 17/628118 YUN; Hongruo ;   et al. | 2022-08-25 |
HUMANIZED ANTIBODIES TO MUCIN-16 AND METHODS OF USE THEREOF 20220235143 - 17/609053 SPRIGGS; David ;   et al. | 2022-07-28 |
CONSTRUCTS TARGETING PROSTATE-SPECIFIC MEMBRANE ANTIGEN (PSMA) AND USES THEREOF 20220185910 - 17/253589 LIU; Hong ;   et al. | 2022-06-16 |
COMPOSITIONS FOR PREVENTING OR TREATING VIRAL AND OTHER MICROBIAL INFECTIONS 20220119501 - 17/501955 LIU; Cheng ;   et al. | 2022-04-21 |
NCAGE Code | 4PGQ4 | EUREKA THERAPEUTICS, INC. |
CAGE Code | 4PGQ4 | EUREKA THERAPEUTICS, INC. |
DUNS | 783405850 | EUREKA THERAPEUTICS, INC. |
SEC | 0001386560 | Eureka Therapeutics Inc of CALIFORNIA |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.